IL153359A0 - Peptides, compositions and methods for the treatment of burkholderia cepacia - Google Patents

Peptides, compositions and methods for the treatment of burkholderia cepacia

Info

Publication number
IL153359A0
IL153359A0 IL15335901A IL15335901A IL153359A0 IL 153359 A0 IL153359 A0 IL 153359A0 IL 15335901 A IL15335901 A IL 15335901A IL 15335901 A IL15335901 A IL 15335901A IL 153359 A0 IL153359 A0 IL 153359A0
Authority
IL
Israel
Prior art keywords
peptides
compositions
treatment
methods
burkholderia cepacia
Prior art date
Application number
IL15335901A
Other languages
English (en)
Original Assignee
Hercules Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hercules Inc filed Critical Hercules Inc
Publication of IL153359A0 publication Critical patent/IL153359A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/46—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=C=S groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00—Specific treatment goals
    • C02F2303/20—Prevention of biofouling
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2305/00—Use of specific compounds during water treatment
    • C02F2305/14—Additives which dissolves or releases substances when predefined environmental conditions are reached, e.g. pH or temperature
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL15335901A 2000-06-16 2001-06-15 Peptides, compositions and methods for the treatment of burkholderia cepacia IL153359A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21244000P 2000-06-16 2000-06-16
PCT/US2001/019312 WO2001098364A2 (en) 2000-06-16 2001-06-15 Peptides, compositions and methods for the treatment of burkholderia cepacia

Publications (1)

Publication Number Publication Date
IL153359A0 true IL153359A0 (en) 2003-07-06

Family

ID=22791020

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15335901A IL153359A0 (en) 2000-06-16 2001-06-15 Peptides, compositions and methods for the treatment of burkholderia cepacia

Country Status (10)

Country Link
US (1) US20020051819A1 (xx)
EP (1) EP1292609A2 (xx)
JP (1) JP2004501167A (xx)
AU (1) AU2001269866A1 (xx)
BR (1) BR0111989A (xx)
CA (1) CA2411857A1 (xx)
IL (1) IL153359A0 (xx)
MX (1) MXPA02012249A (xx)
PL (1) PL360507A1 (xx)
WO (1) WO2001098364A2 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI116030B (fi) * 2002-11-06 2005-09-15 Kemira Oyj Paperi- ja kartonkikoneiden termofiilisten mikrobien biofilminmuodostuksen esto
FI115502B (fi) * 2002-11-06 2005-05-31 Kemira Oyj Bakteerien aiheuttaman kertymänmuodostuksen estäminen paperi- ja kartonkikoneiden pinnoille
GB0413950D0 (en) * 2004-06-22 2004-07-28 Ebiox Ltd Sanitizing method
EP1853620B1 (en) * 2005-02-09 2012-01-11 Helix Biomedix, Inc. Antimicrobial hexapeptides
EP1782819A1 (en) * 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
US9622951B2 (en) 2012-10-29 2017-04-18 The Procter & Gamble Company Personal care compositions
AU2014305760B2 (en) 2013-08-09 2017-06-08 Puretech Scientific Llc Skin care compositions having cyclic diesters and methods thereof
DE112014003589B4 (de) 2013-12-03 2023-10-19 Istanbul Teknik Universitesi Eine antibakterielle Membran und ein Herstellungsverfahren dafür
US20170000696A1 (en) * 2015-03-24 2017-01-05 The Procter & Gamble Company Methods of applying a high dose of a skin care active to skin with improved sensory benefits to the skin
US20170000711A1 (en) * 2015-03-24 2017-01-05 The Procter & Gamble Company Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin
CN104958283A (zh) * 2015-06-02 2015-10-07 北京盛大康成医疗技术有限公司 弱碱性皮肤粘膜清洗消毒组合物及其制造方法和用途
CN105350284A (zh) * 2015-12-18 2016-02-24 苏州富美纺织科技有限公司 织物整理液的制备方法
CN107114401A (zh) * 2017-03-29 2017-09-01 岳阳云秋珍珠科技有限公司 一种蓝藻清除剂及其制备方法
WO2020250242A1 (en) * 2019-06-10 2020-12-17 Godrej Agrovet Limited Bud break formulation
KR102300141B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리 패션 스타일 춘추 잠바
KR102300142B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리 패션 스타일 동계용 잠바
KR102300143B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리룩 스타일 동계용 잠바
US11806405B1 (en) 2021-07-19 2023-11-07 Zeno Management, Inc. Immunoconjugates and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5328169A (en) * 1976-08-30 1978-03-16 Suntory Ltd Novel peptide and antibacterial agent
ATE176239T1 (de) * 1990-11-21 1999-02-15 Iterex Pharma Lp Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen
US5786324A (en) * 1994-03-24 1998-07-28 Regents Of The University Of Minnesota Synthetic peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use
US5679364A (en) * 1995-06-07 1997-10-21 Lee County Mosquito Control District Compositions and methods for reducing the amount of contaminants in aquatic and terrestrial environments
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound

Also Published As

Publication number Publication date
CA2411857A1 (en) 2001-12-27
WO2001098364A3 (en) 2002-05-16
EP1292609A2 (en) 2003-03-19
MXPA02012249A (es) 2004-01-26
US20020051819A1 (en) 2002-05-02
WO2001098364A2 (en) 2001-12-27
BR0111989A (pt) 2003-04-01
AU2001269866A1 (en) 2002-01-02
PL360507A1 (en) 2004-09-06
JP2004501167A (ja) 2004-01-15

Similar Documents

Publication Publication Date Title
IL245955B (en) Immunogenic preparations for the prevention and treatment of inflammatory bowel disease
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL153359A0 (en) Peptides, compositions and methods for the treatment of burkholderia cepacia
AU6147401A (en) Compositions and methods for the treatment of cancer
HUP0400231A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
PL364995A1 (en) Method for the treatment or prevention of flavivirus
AUPR105400A0 (en) Processes and compositions for water treatment
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
PL377443A1 (pl) Kompozycja do leczenia zmarszczek, drobnych zmarszczek i nadmiernego pocenia się oraz sposób jej zastosowania
HU0103078D0 (en) Pharmaceutical compositions and methods for treating cataracts
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
ZA200302014B (en) Methods and compositions for promoting the maturation of monocytes.
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
IL153487A0 (en) Pharmaceutical compositions and methods for use
EP1183011A4 (en) METHOD FOR THE TREATMENT OF ANGINA AND / OR SIMILAR ILLNESSES AND THE MEDICINAL PRODUCTS AND KITS THEREOF
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
IL153897A0 (en) Pharmaceutical compositions and methods for use
AU5565401A (en) Materials and methods for the treatment of depression
MXPA03006255A (es) Composiciones farmaceuticas que comprenden peptidos derivados del sistema nervioso central modificados para promover regeneracion de nervios y prevencion de degeracion de nervios.
ZA200210361B (en) Method of administering bishosphonates.
EP1250145A4 (en) PEPTIDES DERIVED FROM ONCOGENE C-SKI FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF CANCER
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease